Skip to content
Review

Mitochondrial homeostasis dysregulation: Potential mechanisms of Alzheimer's disease mediated by TDP-43.

Aug 2026 · Ageing Research Reviews · pp. 103290 · 3 citations · 144 references
Medicine

TL;DR

Key features of mitochondrial homeostasis in neurons are outlined, neuropathological and clinical data supporting the relevance of TDP-43 in AD are reviewed, and emerging mechanisms by which TDP-43 may perturb mitochondrial homeostasis are synthesized.

Abstract

Alzheimer's disease (AD) exhibits substantial clinical and pathological heterogeneity that is not fully explained by amyloid-β and tau pathology alone. TAR DNA-binding protein 43 (TDP-43) is increasingly recognized as a frequent copathology in AD, particularly in limbic regions, where its presence is associated with accelerated cognitive decline. Disruption of mitochondrial homeostasis is also an early and consistent feature of AD and contributes to neuronal vulnerability. In this review, we summarize current evidence linking TDP-43 pathology to impaired mitochondrial homeostasis in AD. We outline key features of mitochondrial homeostasis in neurons, review neuropathological and clinical data supporting the relevance of TDP-43 in AD, and synthesize emerging mechanisms by which TDP-43 may perturb mitochondrial homeostasis, including effects on expression, aggregation and localization, quality control, organelle dynamics, and endoplasmic reticulum-mitochondria communication.

View source

Similar papers

Open access 2026

Mitochondrial Calcium Dysregulation: A Central Nexus in Alzheimer’s Disease Pathogenesis and Therapeutic Intervention

Research in Alzheimer’s disease (AD) has been primarily focused on the genetic causes and therapies to target the amyloid‑β (Aβ) plaques and neurofibrillary tau tangles (NFTs). However, a growing body of research suggests that imbalances and subsequent breakdown in mitochondrial calcium (Ca²⁺) regulation plays a centra...

Sahishnu Saha · 0 citations
Open access Jul 2026

Mitochondrial accumulation and lysosomal dysfunction result in mitochondrial plaques in Alzheimer's disease.

It is shown that AD model mice expressing a mitophagy reporter (APP/PSEN1/mt-Keima) develop large accumulation of acidic and neutral mitochondria within neuronal processes that form a previously unrecognized pathological structure termed mitochondrial plaques (MPs).

Xiuli Dan, D. L. Croteau, Wenlong Liu et al. · 1 citation
Aug 2026

Distinct Transcriptional States of TDP-43 Pathology in an Alzheimer's Disease Mouse Model.

A transcriptional framework linking early TDP-43 stress responses to pathological aggregation in AD is provided, and potential upstream therapeutic targets are revealed, including ERK1/2, PI3K, small GTPases, and mRNA splicing pathways.

Ji-Chuan Liu, Wen-Jin Liu, Li-Qiang Yu et al. · 0 citations
Review Open access Aug 2026

Mitochondrial dynamics in Huntington's disease.

Emerging evidence suggests a central and early role of mitochondrial dysfunction, including altered mitochondrial dynamics, in Huntington's disease (HD) pathogenesis. Processes such as mitochondrial fission, fusion, transport and mitophagy are vital for proper mitochondrial function and seem to be key mediators of neur...

B. Paiva, A. Cristina Rego · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.